Fixed dose combinations [Design Issues]

posted by kumarnaidu – Mumbai, India, 2014-03-19 11:43 (4477 d 17:29 ago) – Posting: # 12664
Views: 5,326

Dear All,
If we want to demonstrate BE for an FDC in which one drug is highly variable (CV>30%)and other one with CV ~20% then in this case should we opt scaled approach(replicate design) or 2x2 crosover design?

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
143 visitors (0 registered, 143 guests [including 32 identified bots]).
Forum time: 06:12 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5